What You Ought to Know:
– Thoma Bravo, a non-public fairness funding agency targeted on the software program and technology-enabled providers sector introduced that it has reached an settlement to amass Greenphire, a monetary lifecycle administration software program for medical trials, from The Riverside Firm. Monetary particulars weren’t disclosed for the pending transaction.
– The acquisition, which is topic to customary regulatory approvals, is predicted to shut within the second quarter of this 12 months.
– Jim Murphy, CEO of Greenphire, will proceed to guide the corporate together with the present administration staff in King of Prussia, PA.
Monetary Options for Smarter Scientific Trials
Many medical trial professionals cite related, ongoing challenges all through every stage of a medical trial. From points with trial design and delays in examine start-up to burdensome fee workflows and tough affected person recruitment and retention.
Based in 2008, Greenphire permits pharmaceutical trade leaders worldwide to run extra environment friendly and profitable medical trials. The corporate’s end-to-end options optimize medical trial efficiency by streamlining fee and logistical workflows from sponsors and contract analysis organizations (CROs) to websites and sufferers in additional than 70 international locations.
Up to now, Greenphire has earned the place of trusted accomplice for a broad array of shoppers together with the vast majority of the highest 30 pharmaceutical corporations and prime 10 CROs in addition to main investigative analysis websites. Utilizing the corporate’s versatile SaaS answer suite, sponsors, CROs and analysis websites are in a position to assist trials of any design and complexity whereas accommodating regional workflow preferences and nuanced regulatory necessities.
“Our acquisition by Thoma Bravo is additional validation of our technique and the distinctive worth we offer our shoppers, notably as pharmaceutical corporations and CROs speed up traits in direction of participant centricity of their medical trials,” mentioned Jim Murphy, CEO of Greenphire. “We’ve got continued to set the usual for monetary workflow automation and affected person comfort in medical trials on a world scale and sit up for constructing on our progress and success throughout this new chapter with Thoma Bravo.”